These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 1635937)

  • 1. Efficacy of low vs. high doses of levosulpiride on negative symptoms of schizophrenia.
    Catapano F; Maj M; Grimaldi F; Ventra C; Kemali D
    Pharmacopsychiatry; 1992 May; 25(3):166. PubMed ID: 1635937
    [No Abstract]   [Full Text] [Related]  

  • 2. Ziprasidone and amisulpride effectively treat negative symptoms of schizophrenia: results of a 12-week, double-blind study.
    Olié JP; Spina E; Murray S; Yang R
    Int Clin Psychopharmacol; 2006 May; 21(3):143-51. PubMed ID: 16528136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-blind study of clocapramine and sulpiride in hospitalized chronic schizophrenic patients.
    Yamagami S; Kiriike N; Kawaguchi K
    Drugs Exp Clin Res; 1988; 14(11):707-13. PubMed ID: 3246215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled study of the disinhibiting effect of low doses of sulpiride in severe schizophrenic psychoses].
    Petit M; Zann M; Colonna L
    Encephale; 1984; 10(1):25-8. PubMed ID: 6145580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Three antipsychotic drugs in the treatment of schizophrenia--a controlled and double-blind study].
    Yang WJ
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Oct; 21(5):277-80, 318-9. PubMed ID: 3069383
    [No Abstract]   [Full Text] [Related]  

  • 6. Zotepine versus placebo in the treatment of schizophrenic patients with stable primary negative symptoms: a randomized double-blind multicenter trial.
    Möller HJ; Riedel M; Müller N; Fischer W; Kohnen R
    Pharmacopsychiatry; 2004 Nov; 37(6):270-8. PubMed ID: 15551193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lurasidone in the treatment of acute schizophrenia: a double-blind, placebo-controlled trial.
    Nakamura M; Ogasa M; Guarino J; Phillips D; Severs J; Cucchiaro J; Loebel A
    J Clin Psychiatry; 2009 Jun; 70(6):829-36. PubMed ID: 19497249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1st results in the treatment of schizophrenic syndromes using sulpiride].
    Colucci D'Amato C; Luciano LR
    Acta Neurol (Napoli); 1973; 28(6):714-29. PubMed ID: 4593209
    [No Abstract]   [Full Text] [Related]  

  • 9. [Benzamides, a therapeutic response adapted to 2 sides, paranoid and hebephrenic, of schizophrenia].
    Cassan P
    Ann Med Psychol (Paris); 1985 Jul; 143(7):677-82. PubMed ID: 2870674
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinico-pharmacological studies of sulpiride.
    Nishiura M
    Curr Ther Res Clin Exp; 1976 Aug; 20(2):164-72. PubMed ID: 821717
    [No Abstract]   [Full Text] [Related]  

  • 11. A double blind controlled study of ECT vs chlorpromazine in schizophrenia.
    Bagadia VN; Abhyankar RR; Doshi J; Pradhan PV; Shah LP
    J Assoc Physicians India; 1983 Oct; 31(10):637-40. PubMed ID: 6671932
    [No Abstract]   [Full Text] [Related]  

  • 12. Dopaminergic deficit and the role of amisulpride in the treatment of schizophrenia.
    Kasper S
    Int Clin Psychopharmacol; 2002 Dec; 17 Suppl 4():S19-26. PubMed ID: 12685918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THE LESSA (Lebanese Short-term Study with Amisulpride) STUDY a Phase IV clinical trial in acutely ill schizophrenic patients.
    Baddoura R; Ourgandjian H
    J Med Liban; 2004; 52(2):78-85. PubMed ID: 15884686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of sulpride on long standing hospitalized schizophrenic patients].
    Eckmann F
    Arzneimittelforschung; 1974 Jul; 24(7):993-4. PubMed ID: 4603403
    [No Abstract]   [Full Text] [Related]  

  • 15. Augmentation of clozapine with amisulpride: a promising therapeutic approach to refractory schizophrenic symptoms.
    Kämpf P; Agelink MW; Naber D
    Pharmacopsychiatry; 2005 Jan; 38(1):39-40. PubMed ID: 15706467
    [No Abstract]   [Full Text] [Related]  

  • 16. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
    Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
    Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of sulpiride and chlorpromazine on depressive symptoms in schizophrenic patients--relationship to drug concentrations.
    Alfredsson G; Härnryd C; Wiesel FA
    Psychopharmacology (Berl); 1984; 84(2):237-41. PubMed ID: 6438683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies with sulpiride in schizophrenics hospitalized for many years].
    Eckmann F
    Agressologie; 1978; 19(C):153-6. PubMed ID: 375761
    [No Abstract]   [Full Text] [Related]  

  • 19. [Trial with sulpiride in hospitalized schizophrenic patients].
    Martins C; Neves DF; Gama GA; Gavioli HR; Carvalho IM; Amaral MA; Vieira NC; Oliveira RB; Leal WG; Assis LM
    Arq Neuropsiquiatr; 1974 Sep; 32(3):228-33. PubMed ID: 4411367
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlled trial of sulpiride in chronic schizophrenic patients.
    Edwards JG; Alexander JR; Alexander MS; Gordon A; Zutchi T
    Br J Psychiatry; 1980 Dec; 137():522-9. PubMed ID: 7011469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.